• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carlisle Companies Announces Leadership Appointments

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    $WU
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials
    Get the next $CAH alert in real time by email

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer.

    Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensuring compliance with corporate governance requirements. Prior to Summit Materials, Mr. Gaskill served as Senior Director and Counsel at The Western Union Company (NYSE:WU), Senior Counsel at Cardinal Health Inc. (NYSE:CAH) and an attorney at Simpson, Thacher & Bartlett LLP. Mr. Gaskill holds a Juris Doctor degree from the University of Virginia School of Law.

    Mr. Selbach served as Executive Vice President, Secretary & General Counsel of the Company since January 2023 and Vice President, Secretary & General Counsel from May 2018. Over his more than 30 years of employment with Carlisle, Mr. Selbach has also served as Vice President, Corporate Development and Vice President, Europe.

    Mr. Koch stated, "I am extremely pleased to announce these leadership appointments. Chris is an experienced leader with a broad range of legal and functional expertise and is a proactive, strategic business partner with a strong track record of providing insightful counsel. Scott is a multi-disciplined executive with deep roots in Carlisle who in his new role will work with legislative bodies and government agencies to promote Carlisle's innovative energy-efficient products. These appointments are further examples of how Carlisle continues to invest in exceptional talent in support of our Vision 2030 objectives."

    About Carlisle Companies Incorporated

    Carlisle Companies Incorporated is a leading supplier of innovative building envelope products and solutions for more energy efficient buildings. Through its building products businesses – Carlisle Construction Materials ("CCM") and Carlisle Weatherproofing Technologies ("CWT") – and family of leading brands, Carlisle delivers innovative, labor reducing and environmentally responsible products and solutions to customers through the Carlisle Experience. Carlisle is committed to generating superior shareholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Leveraging its culture of continuous improvement as embodied in the Carlisle Operating System ("COS"), Carlisle has committed to achieving net-zero greenhouse gas emissions by 2050.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250515593954/en/

    Mehul Patel

    Vice President, Investor Relations

    Carlisle Companies Incorporated

    (310) 592 - 9668

    [email protected]

    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAH
    $CSL
    $SUM
    $WU

    CompanyDatePrice TargetRatingAnalyst
    Carlisle Companies Incorporated
    $CSL
    1/30/2026Mkt Perform
    William Blair
    Western Union Company
    $WU
    1/27/2026$9.00Underweight
    Cantor Fitzgerald
    Cardinal Health Inc.
    $CAH
    1/9/2026Neutral → Buy
    Citigroup
    Cardinal Health Inc.
    $CAH
    12/9/2025$243.00Overweight
    Barclays
    Western Union Company
    $WU
    10/23/2025$9.00Neutral
    Citigroup
    Carlisle Companies Incorporated
    $CSL
    10/20/2025Hold
    Vertical Research
    Carlisle Companies Incorporated
    $CSL
    7/31/2025$395.00Buy → Hold
    Loop Capital
    Western Union Company
    $WU
    7/29/2025$7.50 → $7.00Sell
    Monness Crespi & Hardt
    More analyst ratings

    $CAH
    $CSL
    $SUM
    $WU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Europe, Africa, MEPA Angelini Giovanni bought $89,540 worth of shares (10,000 units at $8.95), increasing direct ownership by 6% to 186,932 units (SEC Form 4)

    4 - Western Union CO (0001365135) (Issuer)

    11/12/25 6:01:08 AM ET
    $WU
    Real Estate

    CEO & President Mcgranahan Devin bought $1,498,054 worth of shares (176,470 units at $8.49), increasing direct ownership by 24% to 913,125 units (SEC Form 4)

    4 - Western Union CO (0001365135) (Issuer)

    8/25/25 4:12:16 PM ET
    $WU
    Real Estate

    Chief Financial Officer Cagwin Matthew bought $146,300 worth of shares (17,500 units at $8.36), increasing direct ownership by 8% to 225,611 units (SEC Form 4)

    4 - Western Union CO (0001365135) (Issuer)

    8/20/25 4:28:06 PM ET
    $WU
    Real Estate

    $CAH
    $CSL
    $SUM
    $WU
    SEC Filings

    View All

    SEC Form 10-K filed by Western Union Company

    10-K - Western Union CO (0001365135) (Filer)

    2/20/26 4:07:47 PM ET
    $WU
    Real Estate

    Western Union Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Western Union CO (0001365135) (Filer)

    2/20/26 7:00:24 AM ET
    $WU
    Real Estate

    SEC Form 10-K filed by Carlisle Companies Incorporated

    10-K - CARLISLE COMPANIES INC (0000790051) (Filer)

    2/13/26 2:18:17 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CAH
    $CSL
    $SUM
    $WU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Carlisle Cos

    William Blair initiated coverage of Carlisle Cos with a rating of Mkt Perform

    1/30/26 6:58:54 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Cantor Fitzgerald initiated coverage on Western Union with a new price target

    Cantor Fitzgerald initiated coverage of Western Union with a rating of Underweight and set a new price target of $9.00

    1/27/26 8:50:52 AM ET
    $WU
    Real Estate

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    $CSL
    $SUM
    $WU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Western Union Reports Fourth Quarter and Full Year 2025 Results

    Q4 GAAP revenue of $1.0 billion, down 5% on both a reported basis and an adjusted basis; full year GAAP revenue of $4.1 billion, down 4% on a reported basis, and 2% on an adjusted basis, excluding Iraq Q4 Consumer Services GAAP revenue grew 15%, or 26% on an adjusted basis; full year GAAP revenue grew 32%, or 29% on an adjusted basis Both Q4 and full year Branded Digital GAAP revenue grew 7%, or 6% on an adjusted basis Q4 GAAP EPS of $0.36 or adjusted EPS of $0.45; full year GAAP EPS of $1.52 or adjusted EPS of $1.75 Board of Directors approved a dividend of $0.235 per share in the first quarter of 2026 The Western Union Company (the "Company" or "Western Union") (NYSE:WU) t

    2/20/26 7:00:00 AM ET
    $WU
    Real Estate

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%

    2/5/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    $CSL
    $SUM
    $WU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP & Chief Accounting Officer Easton Andrew C exercised 300 shares at a strike of $150.00 and sold $94,964 worth of shares (233 units at $407.57), increasing direct ownership by 8% to 926 units (SEC Form 4)

    4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

    2/19/26 4:18:25 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    Chief Financial Officer Alt Aaron E covered exercise/tax liability with 1,914 shares and sold $524,964 worth of shares (2,328 units at $225.50), decreasing direct ownership by 14% to 26,408 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    2/18/26 4:25:35 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Vice Chair of CCM Schwar Stephen exercised 1,500 shares at a strike of $108.72 and sold $2,524,584 worth of shares (6,049 units at $417.36), decreasing direct ownership by 35% to 8,540 units (SEC Form 4)

    4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

    2/13/26 11:39:59 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CAH
    $CSL
    $SUM
    $WU
    Leadership Updates

    Live Leadership Updates

    View All

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) is pleased to announce that, effective November 3, 2025, Jason Taylor will join the company as President of its Construction Materials business (CCM). As part of this transition, Steve Schwar will assume the role of Vice Chair of CCM to ensure a smooth and effective leadership transition. Both Mr. Taylor and Mr. Schwar will report to Chris Koch, Carlisle's Chair, President, and Chief Executive Officer. Mr. Taylor has joined CCM after more than 14 years at Beacon Building Products, now known as QXO, Inc., a leading distributor of roofing and complementary building products. At Beacon, Mr. Taylor held several key leadership roles, including most re

    11/3/25 9:00:00 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Bentley Systems Set to Join S&P MidCap 400 and Western Union to Join S&P SmallCap 600

    NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Bentley Systems Inc. (NASD: BSY) will replace Western Union Co. (NYSE:WU) in the S&P MidCap 400, and Western Union will replace Mr. Cooper Group Inc. (NASD: COOP) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 6. Rocket Companies Inc. (NYSE:RKT) acquired Mr. Cooper Group in a deal that closed today, October 1. Western Union's market capitalization is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name        Action Company Name Ticker GICS Sector October 6, 2025   S&P MidCap

    10/1/25 6:03:00 PM ET
    $BSY
    $RKT
    $SPGI
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $CAH
    $CSL
    $SUM
    $WU
    Financials

    Live finance-specific insights

    View All

    Western Union Reports Fourth Quarter and Full Year 2025 Results

    Q4 GAAP revenue of $1.0 billion, down 5% on both a reported basis and an adjusted basis; full year GAAP revenue of $4.1 billion, down 4% on a reported basis, and 2% on an adjusted basis, excluding Iraq Q4 Consumer Services GAAP revenue grew 15%, or 26% on an adjusted basis; full year GAAP revenue grew 32%, or 29% on an adjusted basis Both Q4 and full year Branded Digital GAAP revenue grew 7%, or 6% on an adjusted basis Q4 GAAP EPS of $0.36 or adjusted EPS of $0.45; full year GAAP EPS of $1.52 or adjusted EPS of $1.75 Board of Directors approved a dividend of $0.235 per share in the first quarter of 2026 The Western Union Company (the "Company" or "Western Union") (NYSE:WU) t

    2/20/26 7:00:00 AM ET
    $WU
    Real Estate

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%

    2/5/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    $CSL
    $SUM
    $WU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Summit Materials Inc.

    SC 13D/A - Summit Materials, Inc. (0001621563) (Subject)

    11/25/24 9:19:55 AM ET
    $SUM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Amendment: SEC Form SC 13G/A filed by Summit Materials Inc.

    SC 13G/A - Summit Materials, Inc. (0001621563) (Subject)

    11/14/24 1:22:36 PM ET
    $SUM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    SEC Form SC 13G filed by Western Union Company

    SC 13G - Western Union CO (0001365135) (Subject)

    11/14/24 1:22:35 PM ET
    $WU
    Real Estate